₨ Official source-observed price
PKR 3,176.37
30's
PKR 105.88 / tablet
✓ Official DRAP price source observed · Source checked 2026-09-23
Price Intelligence
Equivalent price position
Same generic · strength · dosage form · compatible unitPrice Intelligence PRO →
This brandPKR 105.88/ tablet
Price positionNear medianvs like-for-like peer median
Peer comparators7current-price listings
🔒
MedInfoBase Pharma Pro
View Price Intelligence PRO
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Rank & percentilePeer medianFull competitor listPortfolio intelligence
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Lamivudine + Zidovudine
- Therapeutic area
- Anti-infectives
- Drug class
- Antivirals
- ATC
- J05AR
- Strength
- 150 mg + 300 mg
- Dosage form
- Tablet
- Pack
- 30's
- Registration no.
- 039709
- Price record verified
- 2026-08-09
- Latest DRAP source check
- 2026-09-23 03:18
Manufacturer
Nabiqasim Industries (Pvt) Ltd.,
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →Traceability
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 3,176.37 | 2026-07-23 | 2026-08-09 | DRAP PharmaPrice Index | Current |
Same generic
Other listed brands
COFIF 150 mg + 300 mgAGP Limited · PKR 1,039.40COMBIVIRIN 150 mg + 300 mgCCL Pharmaceuticals (Pvt.) Limited · PKR 2,065.31COMBIVIRIN 150 mg + 300 mgCCL Pharmaceuticals (Pvt.) Limited · PKR 6,195.91COMBIVIRIN 150 mg + 300 mgCCL Pharmaceuticals (Pvt.) Limited · PKR 3,097.96DUOVIR + 150 mg + 300 mgAJM Pharma (Pvt.) Limited · PKR 5,811.81Lamizid 150 mg + 300 mgBosch Pharmaceuticals (Pvt) Ltd. · PKR 6,861.26Lamozid 150 mg + 300 mgNabiqasim Industries (Pvt) Ltd., · PKR 1,058.79
Evidence note: “Source observed” means MedInfoBase captured the record from an official DRAP source; it does not by itself mean the product registration was independently matched in the DRAP registry. Price note: Unit-price comparisons are informational calculations from official-source pack prices and normalized pack quantities. A pharmacy's transaction price may differ. Verify current regulatory and product information before professional use.
Cite this record
Medicine record · DRAP registration 039709MedInfoBase. (2026). Lamozid 150 mg + 300 mg Tablet (30's), Nabiqasim Industries (Pvt) Ltd., — registration and price record [Data set]. MedInfoBase. Retrieved September 23, 2026, from https://medinfobase.com/brand/lamozid-150-mg-300-mg-039709-10s-nabiqasim-industries-pvt-ltd/ Data observed 9 August 2026. Source: DRAP PharmaPrice Index. DRAP registration 039709.
MedInfoBase. Lamozid 150 mg + 300 mg Tablet (30's), Nabiqasim Industries (Pvt) Ltd., — registration and price record [Internet]. Islamabad: MedInfoBase; 2026 [cited 2026 Sep 23]. Available from: https://medinfobase.com/brand/lamozid-150-mg-300-mg-039709-10s-nabiqasim-industries-pvt-ltd/ Data observed 9 August 2026. Source: DRAP PharmaPrice Index. DRAP registration 039709.
MedInfoBase (2026) Lamozid 150 mg + 300 mg Tablet (30's), Nabiqasim Industries (Pvt) Ltd., — registration and price record. Available at: https://medinfobase.com/brand/lamozid-150-mg-300-mg-039709-10s-nabiqasim-industries-pvt-ltd/ (Accessed: 23 September 2026).
"Lamozid 150 mg + 300 mg Tablet (30's), Nabiqasim Industries (Pvt) Ltd., — registration and price record." MedInfoBase, 2026, https://medinfobase.com/brand/lamozid-150-mg-300-mg-039709-10s-nabiqasim-industries-pvt-ltd/. Accessed 23 Sep 2026.
MedInfoBase. 2026. "Lamozid 150 mg + 300 mg Tablet (30's), Nabiqasim Industries (Pvt) Ltd., — registration and price record." Accessed September 23, 2026. https://medinfobase.com/brand/lamozid-150-mg-300-mg-039709-10s-nabiqasim-industries-pvt-ltd/.
Price and registration data on this page were observed on 9 August 2026. Records change over time, so please cite the observation date alongside the access date.